Literature DB >> 9702524

A marked increase in free copper levels in the plasma and liver of LEC rats: an animal model for Wilson disease and liver cancer.

M Koizumi1, J Fujii, K Suzuki, T Inoue, T Inoue, J M Gutteridge, N Taniguchi.   

Abstract

Most of copper present in rat plasma and liver binds to caeruloplasmin and metallothionein, respectively, and is not redox active. However, free forms of copper including loosely bound forms to other molecules are redox active. We assessed the free copper in Long-Evans rats with a cinnamon-like coat color (LEC rats), an animal model of Wilson disease and liver cancer. Compared to those of control rats, the liver and plasma of LEC rats showed a marked elevation of free copper, especially at the stage of acute hepatitis, in parallel with an increase of total copper levels in the livers and a decrease of plasma caeruloplasmin (ferroxidase I) activity. At the onset of jaundice, the total copper levels, however, decreased in liver, but increased in plasma, while free copper levels in both liver and plasma remained higher. Free iron levels in both liver and plasma were also determined and did not change significantly, except for the case of plasma in jaundiced rats. The data are consistent with a proposal in which increased levels of redox active free copper in the liver of LEC rats catalyze Fenton-type reactions, producing a large flux of hydroxyl radicals that would play an important role in the observed liver dysfunction, leading to acute hepatitis, and finally, hepatocarcinoma. This is the first demonstration that the free copper may participate in the pathophysiology of the LEC rats and Wilson disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9702524     DOI: 10.3109/10715769809066881

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  5 in total

Review 1.  Antioxidants in health and disease.

Authors:  I S Young; J V Woodside
Journal:  J Clin Pathol       Date:  2001-03       Impact factor: 3.411

2.  Dietary Zinc Supplementation to Prevent Chronic Copper Poisoning in Sheep.

Authors:  Antonio Humberto Hamad Minervino; Marta López-Alonso; Raimundo Alves Barrêto Júnior; Frederico Augusto Mazzocca Lopes Rodrigues; Carolina Akiko Sato Cabral Araújo; Rejane Santos Sousa; Clara Satsuk Mori; Marta Miranda; Francisco Leonardo Costa Oliveira; Alexandre Coutinho Antonelli; Enrico Lippi Ortolani
Journal:  Animals (Basel)       Date:  2018-11-30       Impact factor: 2.752

3.  Iron metabolism is disturbed and anti-copper treatment improves but does not normalize iron metabolism in Wilson's disease.

Authors:  Grażyna Gromadzka; Diana Wierzbicka; Tomasz Litwin; Adam Przybyłkowski
Journal:  Biometals       Date:  2021-02-08       Impact factor: 2.949

4.  Cuproptosis-Related Risk Score Predicts Prognosis and Characterizes the Tumor Microenvironment in Hepatocellular Carcinoma.

Authors:  Zhen Zhang; Xiangyang Zeng; Yinghua Wu; Yang Liu; Xi Zhang; Zewen Song
Journal:  Front Immunol       Date:  2022-07-11       Impact factor: 8.786

5.  Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma.

Authors:  Xingyu Peng; Jinfeng Zhu; Sicheng Liu; Chen Luo; Xun Wu; Zitao Liu; Yanzhen Li; Rongfa Yuan
Journal:  Front Immunol       Date:  2022-09-28       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.